Title
Category
Credits
Event date
Cost
Advances in the Management of Coronary Artery Disease Utilizing CCTA and CAC Scoring
  • Cardiology
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This on-demand webcast is designed to provide updated knowledge on the diagnosis and management of coronary artery disease (CAD) with a focus on the benefits of coronary computed tomography angiography (CCTA) and coronary artery calcium (CAC) scoring. It will explore the diagnostic accuracy, patient safety, and clinical outcomes associated with CCTA and compare this approach to traditional functional-stress-testing methods. The utilization of CAC scoring for risk assessment and in the evaluation of low-risk chest pain will be highlighted, and the role of the primary care physician (PCP) in implementing a CCTA-first approach will be discussed.
Modern Approaches to Managing Chronic Obstructive Pulmonary Disease
  • Cardiology
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore the latest advancements in the management and treatment of chronic obstructive pulmonary disease (COPD) drawn from the most recent guidelines and research findings and highlighted in the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report.
Heart Failure: Diagnosis and Initial Management for the Primary Care Provider
  • Cardiology
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This on-demand webcast is designed to enhance primary care providers’ understanding of the evolving landscape of heart failure classification and treatment. Participants will explore the current nomenclature for heart failure staging and functional classification, with a focus on stratification by ejection fraction. The session will review the latest guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), including updates on pharmacologic and device-based interventions. Additionally, common barriers to implementing optimal therapy will be discussed, along with practical strategies to improve adherence and patient outcomes.